Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma
NCT00111774
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Cancer
Carcinoma
Interventions
DRUG:
ABX-EGF
Sponsor
Amgen